Where Ventyx Biosciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for Ventyx Biosciences (NASDAQ:VTYX) in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for Ventyx Biosciences has increased by 1.62% from the previous average, now standing at $56.5.
August 29, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ventyx Biosciences has received positive ratings from analysts, which could potentially boost investor confidence and positively impact the stock price.
Analyst ratings often influence investor sentiment and can impact stock prices. The positive ratings for Ventyx Biosciences, along with an increased 12-month price target, suggest a positive outlook for the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100